Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2004

Fidda N, Miron J, Rodgers WH, Rader A. Impact of the new Bethesda System 2001 on specimen adequacy of conventional cervicovaginal smears. Diagn Cytopathol. 2004;30(4):235-9.

C Wilcox M, Rodgers W, Lazenby A. Prospective comparison of brush cytology, viral culture, and histology for the diagnosis of ulcerative esophagitis in AIDS. Clin Gastroenterol Hepatol. 2004;2(7):564-7.

Ramiro AR, Jankovic M, Eisenreich T, Difilippantonio S, Chen-Kiang S, Muramatsu M, et al. AID is required for c-myc/IgH chromosome translocations in vivo. Cell. 2004;118(4):431-8.

Korkmaz CG, Korkmaz KS, Manola J, Xi Z, Risberg B, Danielsen H, et al. Analysis of androgen regulated homeobox gene NKX3.1 during prostate carcinogenesis. J Urol. 2004;172(3):1134-9.

Takahashi C, Contreras B, Bronson RT, Loda M, Ewen ME. Genetic interaction between Rb and K-ras in the control of differentiation and tumor suppression. Mol Cell Biol. 2004;24(23):10406-15.

Sboner A, Bauer P, Zumiani G, Eccher C, Blanzieri E, Forti S, et al. Clinical validation of an automated system for supporting the early diagnosis of melanoma. Skin Res Technol. 2004;10(3):184-92.

Fiorucci S, Distrutti E, Mencarelli A, Rizzo G, Di Lorenzo AR, Baldoni M, et al. Cooperation between aspirin-triggered lipoxin and nitric oxide (NO) mediates antiadhesive properties of 2-(Acetyloxy)benzoic acid 3-(nitrooxymethyl)phenyl ester (NCX-4016) (NO-aspirin) on neutrophil-endothelial cell adherence. J Pharmacol Exp Ther. 2004;309(3):1174-82.

Jiménez M, de Castro IP, Benet M, García JF, Inghirami G, Pellicer A. The Rgr oncogene induces tumorigenesis in transgenic mice. Cancer Res. 2004;64(17):6041-9.

Westblade LF, Ilag LL, Powell AK, Kolb A, Robinson CV, Busby SJ. Studies of the Escherichia coli Rsd-sigma70 complex. J Mol Biol. 2004;335(3):685-92.

Vonderheide RH, Domchek SM, Schultze JL, George DJ, Hoar KM, Chen D-, et al. Vaccination of cancer patients against telomerase induces functional antitumor CD8+ T lymphocytes. Clin Cancer Res. 2004;10(3):828-39.